Phase I/IIa trial of CYT 009 GhrQb in obese patients.

Trial Profile

Phase I/IIa trial of CYT 009 GhrQb in obese patients.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 18 Aug 2011

At a glance

  • Drugs CYT 009 GhrQb (Primary)
  • Indications Obesity
  • Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
  • Sponsors Cytos Biotechnology
  • Most Recent Events

    • 27 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top